REFERENCES

1. Kivimäki M, Strandberg T, Pentti J, et al. Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study. Lancet Diabetes Endocrinol 2022;10:253-63.

2. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med 2002;347:305-13.

3. Vest AR, Chan M, Deswal A, et al. Nutrition, obesity, and cachexia in patients with heart failure: a consensus statement from the heart failure society of America scientific statements committee. J Card Fail 2019;25:380-400.

4. Gómez-Ambrosi J, Salvador J, Rotellar F, et al. Increased serum amyloid a concentrations in morbid obesity decrease after gastric bypass. Obes Surg 2006;16:262-9.

5. Frühbeck G. The adipose tissue as a source of vasoactive factors. Curr Med Chem Cardiovasc Hematol Agents 2004;2:197-208.

6. Russo MJ, Hong KN, Davies RR, et al. The effect of body mass index on survival following heart transplantation: do outcomes support consensus guidelines? Ann Surg 2010;251:144-52.

7. Fisher BW, Huckaby LV, Sultan I, Hickey G, Kilic A. Center-level variations in maximum recipient body mass index in heart transplantation. Am J Cardiol 2021;145:91-6.

8. Foroutan F, Doumouras BS, Ross H, Alba AC. Impact of pretransplant recipient body mass index on post heart transplant mortality: a systematic review and meta-analysis. Clin Transplant 2018;32:e13348.

9. Mehra MR, Canter CE, Hannan MM, et al; International Society for Heart Lung Transplantation (ISHLT) Infectious Diseases; Pediatric and Heart Failure and Transplantation Councils. The 2016 international society for heart lung transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant 2016;35:1-23.

10. Varshney AS, DeFilippis EM, Cowger JA, Netuka I, Pinney SP, Givertz MM. Trends and outcomes of left ventricular assist device therapy: JACC focus seminar. J Am Coll Cardiol 2022;79:1092-107.

11. Vest AR, Schauer PR, Rodgers JE, et al. Obesity and weight loss strategies for patients with heart failure. JACC Heart Fail 2024;12:1509-27.

12. McDowell K, Petrie MC, Raihan NA, Logue J. Effects of intentional weight loss in patients with obesity and heart failure: a systematic review. Obes Rev 2018;19:1189-204.

13. Wickman BE, Enkhmaa B, Ridberg R, et al. Dietary management of heart failure: DASH diet and precision nutrition perspectives. Nutrients 2021;13:4424.

14. Harrington J, Felker GM, Januzzi JL, et al. Worth their weight? An update on new and emerging pharmacologic agents for obesity and their potential role for persons with cardiac conditions. Curr Cardiol Rep 2024;26:61-71.

15. Wang JY, Wang QW, Yang XY, et al. GLP-1 receptor agonists for the treatment of obesity: role as a promising approach. Front Endocrinol 2023;14:1085799.

16. Marso SP, Bain SC, Consoli A, et al; SUSTAIN-6 Investigators. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 2016;375:1834-44.

17. Kosiborod MN, Petrie MC, Borlaug BA, et al; STEP-HFpEF DM Trial Committees and Investigators. Semaglutide in patients with obesity-related heart failure and type 2 diabetes. N Engl J Med 2024;390:1394-407.

18. Ussher JR, Drucker DJ. Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action. Nat Rev Cardiol 2023;20:463-74.

19. Benotti PN, Wood GC, Carey DJ, et al. Gastric bypass surgery produces a durable reduction in cardiovascular disease risk factors and reduces the long-term risks of congestive heart failure. J Am Heart Assoc 2017;6:e005126.

20. Persson CE, Björck L, Lagergren J, Lappas G, Giang KW, Rosengren A. Risk of heart failure in obese patients with and without bariatric surgery in sweden-a registry-based study. J Card Fail 2017;23:530-7.

21. Hughes D, Aminian A, Tu C, et al. Impact of bariatric surgery on left ventricular structure and function. J Am Heart Assoc 2024;13:e031505.

22. daSilva-deAbreu A, Alhafez BA, Curbelo-Pena Y, et al. Bariatric surgery in patients with obesity and ventricular assist devices considered for heart transplantation: systematic review and individual participant data meta-analysis. J Card Fail 2021;27:338-48.

23. Sharma I, Nakanishi H, Hage K, et al. Bariatric surgery and left ventricular assist device in patients with heart failure: a systematic review and meta-analysis. Am J Surg 2023;226:340-9.

24. Orandi BJ, Purvis JW, Cannon RM, et al. Bariatric surgery to achieve transplant in end-stage organ disease patients: a systematic review and meta-analysis. Am J Surg 2020;220:566-79.

25. Leviner DB, Keidar A, Ben-Gal T, Medalion B. Cardiac function recovery following LVAD implantation and bariatric surgery in a morbidly obese patient. J Card Surg 2014;29:740-2.

26. Morrow EH, Pellegrini CA, Mokadam NA, Khandelwal S. Laparoscopic gastric bypass during left ventricular assist device support and ventricular recovery. J Heart Lung Transplant 2014;33:870-1.

27. Hawkins RB, Stortz J, Ayzengart A, Friedman J. Laparoscopic sleeve gastrectomy improves cardiac function for a heart failure patient requiring left ventricular assist device support. Surgery for Obesity and Related Diseases 2018;14:S143.

28. Goldstein BA, Thomas L, Zaroff JG, Nguyen J, Menza R, Khush KK. Assessment of heart transplant waitlist time and pre- and post-transplant failure: a mixed methods approach. Epidemiology 2016;27:469-76.

29. Bakhtiyar SS, Godfrey EL, Ahmed S, et al. Survival on the heart transplant waiting list. JAMA Cardiol 2020;5:1227-35.

30. Chaudhry UI, Kanji A, Sai-Sudhakar CB, Higgins RS, Needleman BJ. Laparoscopic sleeve gastrectomy in morbidly obese patients with end-stage heart failure and left ventricular assist device: medium-term results. Surg Obes Relat Dis 2015;11:88-93.

31. Lim CP, Fisher OM, Falkenback D, et al. Bariatric surgery provides a “bridge to transplant” for morbidly obese patients with advanced heart failure and may obviate the need for transplantation. Obes Surg 2016;26:486-93.

32. Ristow B, Rabkin J, Haeusslein E. Improvement in dilated cardiomyopathy after bariatric surgery. J Card Fail 2008;14:198-202.

33. Samaras K, Connolly SM, Lord RV, Macdonald P, Hayward CS. Take heart: bariatric surgery in obese patients with severe heart failure. Two case reports. Heart Lung Circ 2012;21:847-9.

34. Masarone D, Kittleson MM, Falco L, et al. The ABC of heart transplantation-part 1: indication, eligibility, donor selection, and surgical technique. J Clin Med 2023;12:5217.

35. daSilva-deAbreu A, Alhafez BA, Curbelo-Pena Y, et al. Bariatric surgery in obese patients with ventricular assist devices. BMC Res Notes 2020;13:382.

36. McElderry B, Alvarez P, Hanna M, et al. Outcomes of bariatric surgery in patients with left ventricular assist device. J Heart Lung Transplant 2022;41:914-8.

37. Alsuhibani A, Thompson JR, Wigle PR, et al. Metabolic and bariatric surgery utilization trends in the United States: evidence from 2012 to 2021 national electronic medical records network. Ann Surg Open 2023;4:e317.

38. Jeng EI, Aranda JM Jr, Ahmed M, Klodell CT. Left ventricular assist device and bariatric surgery: a bridge to heart transplant by weight and waiting time reduction. J Card Surg 2016;31:120-2.

39. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-13.

40. Hwang KY, Hwang NC. Facilitating noncardiac surgery for the patient with left ventricular assist device: a guide for the anesthesiologist. Ann Card Anaesth 2018;21:351-62.

41. Stone M, Hinchey J, Sattler C, Evans A. Trends in the management of patients with left ventricular assist devices presenting for noncardiac surgery: a 10-year institutional experience. Semin Cardiothorac Vasc Anesth 2016;20:197-204.

42. Amro A, Murr M. A video case report of LRYGB in a patient with a left ventricular assist device. Surg Obes Relat Dis 2015;11:1406-7.

43. Feldman D, Pamboukian SV, Teuteberg JJ, et al; International Society for Heart and Lung Transplantation. The 2013 international society for heart and lung transplantation guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant 2013;32:157-87.

44. Strong AT, Sharma G, Nor Hanipah Z, et al. Adjustments to warfarin dosing after gastric bypass and sleeve gastrectomy. Surg Obes Relat Dis 2018;14:700-6.

Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/